For sales

📢Highlights from the Week of June 10 – 16, 2025 in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of June 10–16, 2025 ( SCLC, FDA,Priorityreview ) FDA grants priority review to Zepzelca and Atezolizumab combo as a first-line maintenance for extensive-stage SCLC ( FDA, NSAID ) FDA approved Azurity’s XIFYRM injection for the treatment of moderate-to-severe adult pain ( FDA, Expanded indication ) MAVYRET by AbbVie has become the first and only FDA-approved treatment for acute HCV following an expanded indication ( FDA , ODD ) Vascarta’s Vasceptor has secured FDA Orphan Drug Designation for treating sickle cell disease Pg 1/5 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.